ClinicalTrials.govpublic full text
The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity
type 2 diabetes, obese diabetics, obese patients (bmi ≥ 30 kg/m²)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 234371
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.